| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5128cfc84a0fb189fceb3cd240c44493 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2603-74 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D223-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-096 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-096
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-08 |
| filingDate |
1995-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1997-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4749813b64a8bf9aeba858785ae95233
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60b3e71383ede56b5b87a638cf708e90 |
| publicationDate |
1997-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5650406-A |
| titleOfInvention |
Adamantane derivative, process for producing the same, and use thereof |
| abstract |
PCT No. PCT/JP95/00740 Sec. 371 Date Oct. 8, 1996 Sec. 102(e) Date Oct. 8, 1996 PCT Filed Apr. 17, 1995 PCT Pub. No. WO95/28390 PCT Pub. Date Oct. 26, 1995 <IMAGE> (1) A compound represented by general formula (1) or an innocuous salt thereof, a process for producing the same, and a schizophrenia remedy containing the same as the active ingredient (wherein the nitrogeneous ring B represents 3-azabicyclo [3.2.2] nonan-3-yl or 4-azatricyclo [4.3.1.13.8] undecan-4-yl; and R represents hydrogen, lower alkyl, lower alkoxy, hydroxy or halogen). The above compound and salt have a high affinity for sigma-binding sites and are useful as an antischizophrenic drug. |
| priorityDate |
1994-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |